...Doctors Without Borders notes that Gilead is attempting to enforce conditions on the 11 generic drug makers that would prevent the copies from being diverted to countries not covered by the agreement. But the relief organization argues Gilead is doing so in a way that may compromise patients in order to protect its commercial interests.... The relief group worries these moves create an “ugly precedent.”...